Patient Talk

Skip to content

Home
About
Contact
Privacy Policy and Cookie Policy

Patient Talk

Skip to content

Home
About
Contact
Privacy Policy and Cookie Policy

Search for:

Advertisement

Topics

ADHD Alzheimer's Arthritis A to Z of Medical Conditions Autism autoimmune conditions Cancer Cardiovascular disease Children's health Commemorations Dementia Dental health Diabetes Diet Disability Epilepsy Exercise Eye health Fatigue Fibromyalgia Gastrointestinal disorders Healthcare Reform Infectious Diseases Insomnia Invisible Illness Lupus medical awareness Medical Education Mental health Multiple Sclerosis Musculoskeletal health Natural medicine Obesity Pain Pain Management Patient Talk Research Rheumatoid arthritis Skin conditions Sleep disorders Social media Vision Vitamins Weight Loss Women's Health

Recent Posts

Good news—Multiple Sclerosis drugs taken while breastfeeding may not affect child development. March 6, 2024
Swapping meat for Quorn lowers bad cholesterol by 10 per cent March 5, 2024
RA and Lupus – Scientists reveal how our cells’ leaky batteries make us sick. March 4, 2024
Are ChatGPT exercise recommendations just what the doctor ordered? March 4, 2024
Understanding genetic risk could save sight and predict multiple sclerosis earlier in young people March 3, 2024

Topics

ADHD Alzheimer's Arthritis A to Z of Medical Conditions Autism autoimmune conditions Cancer Cardiovascular disease Children's health Commemorations Dementia Dental health Diabetes Diet Disability Epilepsy Exercise Eye health Fatigue Fibromyalgia Gastrointestinal disorders Healthcare Reform Infectious Diseases Insomnia Invisible Illness Lupus medical awareness Medical Education Mental health Multiple Sclerosis Musculoskeletal health Natural medicine Obesity Pain Pain Management Patient Talk Research Rheumatoid arthritis Skin conditions Sleep disorders Social media Vision Vitamins Weight Loss Women's Health

Posted on March 13, 2019March 13, 2019 Multiple Sclerosis

Future Without MS – Phase I Stem Cell Trial Shows Promising Results & Hope for Phase II

Image result for Future Without MS - Phase I Stem Cell Trial Shows Promising Results & Hope for Phase II

Researchers at Tisch MSRCNY are dedicated to repairing the damage caused by MS, discovering the cause and developing the cure for multiple sclerosis. Learn more about our research and our hope for a Future Without MS. TischMS.org

Future Without MS – Phase I Stem Cell Trial Shows Promising Results & Hope for Phase II from Tisch MSRCNY Videos on Vimeo.

autoimmune systemic inflammatory response

Post navigation

← ‘No link between MMR and autism,’ major study finds

I’m Autistic! | Getting diagnosed with Autism Spectrum Disorder →

Proudly powered by WordPress | Theme: Adaption by WordPress.com.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Do not sell my personal information.

Settings Accept

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.